Turnstone Biologics Corp. — Form D
Turnstone Biologics Corp. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-18. The offering totals $42.1M, of which $42.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-18
- Form: D
- Accession: 0001764974-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.1M
- Amount sold: $42.1M
- Investors: 13
- Date of first sale: 2019-01-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-330976
Issuer
- Name: Turnstone Biologics Corp.
- CIK: 0001764974
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 920 BROADWAY, NEW YORK, NY, 10010
- Phone: 347-897-5988
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Brad Bolzon | Director | New York, NY |
| Jane Henderson | Executive Officer | New York, NY |
| Rishi Gupta | Director | New York, NY |
| Patrick Machado | Director | San Diego, CA |
| Jerel Davis | Director | Alameda, CA |
| Stefan Larson | Director | Del Mar, CA |
| Maura Manuel Campbell | Executive Officer | New York, NY |
| Robert Gould | Director | Portland, ME |
| Jose Manuel Otero | Executive Officer | New York, NY |
| Michael Burgess | Director | New York, NY |
| Michael Burgess | Executive Officer | New York, NY |
| Sammy Farah | Director | New York, NY |
| Sammy Farah | Executive Officer | New York, NY |
Other filings by this issuer (1)
More